Prediction: Lilly Will Trade at Record High in 12 Months
Eli Lilly stock is surging on fresh obesity-drug data, fueling bets that the name could push toward a record high wit...
Cutting down on recurring costs can significantly impact your budget. Explore simple strategies to help you save money regularly.
23,186 articlesEli Lilly stock is surging on fresh obesity-drug data, fueling bets that the name could push toward a record high wit...
Procter & Gamble anchors the dividend-growth crowd with a multi-decade streak and strong cash flow. The plain-as-day ...
Investors chasing high monthly yields through the tech-heavy ULTY ETF are wagering on option income to boost income, ...
AGNT, Inc. has completed its corporate transformation, changing its name and moving its domicile to Texas. The move i...
A 75-year-old with a $2.1 million 401(k) must take an RMD of roughly $85,000 in 2026, lifting taxable income into the...
New data confirms Baby Boomers own the majority of U.S. household wealth, fueling debate about intergenerational powe...
Applied Materials is back within reach of the $500 level after a sharp June selloff, fueling renewed debate on whethe...
Two 2x levered SMCI ETFs are delivering divergent outcomes in mid-2026 as AI server demand fluctuates and governance ...
Despite a chorus of buy ratings on Shopify, a dissenting view flags limited upside as AI tools and monetization effor...
Bitcoin collapsed in a high-volume session after the Fed kept rates steady and a hawkish new chair signaled tighter p...
June brought a tech-led rally as Marvell Technology jumped on a price target upgrade. This piece breaks down the move...
Investors weigh a bold forecast that Eli Lilly could hit $1,200 by year-end 2026, betting on GLP-1 drugs and a robust...